Company page

American Oriental Bioengineering

American Oriental Bioengineering (AOBI) is a public company operating in the American market, with a market capitalization of $87.6 million. The company focuses on the development and distribution of bioengineering products. AOBI aims to leverage its expertise in biotechnology to enhance its product offerings and market presence.

profileAOBI:OTCAI content: aiUpdated June 24, 2026/company/american-oriental-bioengineering-inc/c-m3qkyiot
American Oriental Bioengineering logo
Ticker
AOBI:OTC
Asset type
Stock
Market cap
$88
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
OTC
Currency
USD